LeBel Carl 4
4 · Frequency Therapeutics, Inc. · Filed Jan 19, 2021
Insider Transaction Report
Form 4
LeBel Carl
Chief Development Officer
Transactions
- Award
Stock Option
2021-01-15+75,000→ 75,000 totalExercise: $35.85Exp: 2031-01-14→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025.